Trade AbCellera Biologics Inc. - ABCL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.09 |
| Open | 3.18 |
| 1-Year Change | -59.18% |
| Day's Range | 3.13 - 3.24 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 3.08 | 0.10 | 3.36% | 2.98 | 3.17 | 2.92 |
| Jul 24, 2024 | 2.98 | -0.07 | -2.30% | 3.05 | 3.12 | 2.97 |
| Jul 23, 2024 | 3.07 | 0.16 | 5.50% | 2.91 | 3.10 | 2.91 |
| Jul 22, 2024 | 2.98 | 0.00 | 0.00% | 2.98 | 2.98 | 2.91 |
| Jul 19, 2024 | 2.95 | -0.05 | -1.67% | 3.00 | 3.04 | 2.94 |
| Jul 18, 2024 | 3.03 | -0.33 | -9.82% | 3.36 | 3.36 | 3.02 |
| Jul 17, 2024 | 3.34 | 0.02 | 0.60% | 3.32 | 3.57 | 3.32 |
| Jul 16, 2024 | 3.46 | 0.27 | 8.46% | 3.19 | 3.46 | 3.18 |
| Jul 15, 2024 | 3.18 | 0.04 | 1.27% | 3.14 | 3.22 | 3.03 |
| Jul 12, 2024 | 3.09 | -0.05 | -1.59% | 3.14 | 3.22 | 3.05 |
| Jul 11, 2024 | 3.10 | 0.24 | 8.39% | 2.86 | 3.11 | 2.85 |
| Jul 10, 2024 | 2.78 | -0.08 | -2.80% | 2.86 | 2.93 | 2.71 |
| Jul 9, 2024 | 2.79 | 0.06 | 2.20% | 2.73 | 2.84 | 2.63 |
| Jul 8, 2024 | 2.72 | 0.04 | 1.49% | 2.68 | 2.75 | 2.67 |
| Jul 5, 2024 | 2.67 | -0.01 | -0.37% | 2.68 | 2.71 | 2.64 |
| Jul 3, 2024 | 2.69 | -0.06 | -2.18% | 2.75 | 2.80 | 2.67 |
| Jul 2, 2024 | 2.74 | -0.02 | -0.72% | 2.76 | 2.77 | 2.68 |
| Jul 1, 2024 | 2.74 | -0.19 | -6.48% | 2.93 | 2.95 | 2.74 |
| Jun 28, 2024 | 2.94 | 0.10 | 3.52% | 2.84 | 3.00 | 2.84 |
| Jun 27, 2024 | 2.86 | 0.13 | 4.76% | 2.73 | 2.86 | 2.71 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
AbCellera Biologics Inc. Company profile
AbCellera Biologics Inc. (ABCL) is a Canadian biotechnology company that develops antibody discovery platforms. Its full-stack, AI-powered drug discovery platform searches and analyses the database of natural immune systems to find antibodies that can be used by its partners to develop into drugs.
ABCL was established in 2012 as a spin-off from the University of British Columbia (UBC), where Dr Carl Hansen, the company’s founding CEO, was a faculty member from 2005 to 2019.
The Vancouver-based company has collaborations with drug developers ranging from large cap pharmaceuticals to small biotechnology firms. As of the earnings date of 31 December 2021, the company had 156 discovery programmes either completed, in progress or under contract with 36 partners.
As a recent example, AbCellera Biologics teamed with pharma giant Eli Lilly (LLY) to co-develop two antibody therapeutics to treat and prevent Covid-19 utilising ABCL’s technological stack.
Some of the pharmaceutical companies that partnered with ABCL in the past two years include Everest Medicines for oncology or cancer; Kodiak Sciences (KOD) for partnership in eye care, Novarties (NVS), and Gilead Sciences (GILD) for infectious disease.
AbCellera Biologics was listed as a public company and began trading on the NASDAQ stock exchnage under the ticker symbol ‘ABCL’ in December 2020 through an initial public offering (IPO). ABCL’s stock price was set at $20.
You can follow the ups and downs of the ABCL’s stock price at Capital.com. Also, stay on top of the latest AbCellera Biologics’ stock price developments with our live ABCL stock chart.
| Industry: | Biotechnology & Medical Research (NEC) |
2215 Yukon Street
VANCOUVER
BRITISH COLUMBIA V5Y 0A1
CA
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com